A venture capital and private equity firm investing in pharmaceutical and healthcare companies.
A venture capital and private equity firm investing in pharmaceutical and healthcare companies.
Paramount BioCapital Asset Management is a venture capital and private equity firm investing in pharmaceutical and healthcare companies that is headquartered in New York City, New York. The firms website is no longer active suggesting Paramount BioCapital Asset Management is no longer in business.
According to Crunchbase (as of December 2019), Paramount BioCapital Asset Management has made 4 investments, 1 lead investment, and 4 exits. Notable investments made by Paramount BioCapital Asset Management include: CEL-SCI, Innovive Pharmaceuticals, Genelabs Technologies, and Chelsea Therapeutics International.